Clinical Measles after Measles Virus Challenge in Simian Immunodeficiency Virus-Infected Measles Virus-Vaccinated Rhesus Monkeys

Permar, Sallie R.; Rao, Srinivas S.; Sun, Yue; Bao, Saran; Buzby, Adam P.; Kang, Helen H.; Letvin, Norman L.
December 2007
Journal of Infectious Diseases;12/15/2007, Vol. 196 Issue 12, p1784
Academic Journal
Understanding the impact of human immunodeficiency virus (HIV) infection on the clinical manifestations and kinetics of measles virus (MV) replication in MV-vaccinated and unvaccinated individuals is important for developing successful vaccine strategies for measles eradication. To model the pathogenesis of MV infection in MV-vaccinated and unvaccinated individuals infected with HIV, previously vaccinated and unvaccinated rhesus monkeys infected with simian immunodeficiency virus (SIV) were challenged with MV and monitored for clinical, virologic, and immunologic sequelae of infection. The magnitude and duration of MV viremia were unchanged by SIV infection. Nevertheless, clinical manifestations of MV infection were altered in animals with significant CD4+ T lymphocyte loss. Importantly, 2 of the 3 SIV-infected monkeys with high titers of vaccine-induced MV-neutralizing antibody developed clinical evidence of MV infection. Thus, in this experimental animal model, a high-titer vaccine-induced MV-neutralizing antibody response does not protect against clinical manifestations of measles in the setting of a chronic acquired immunodeficiency syndrome virus infection.


Related Articles

  • Less Measles--Really Down This Time? Polk, Lewis D. // Clinical Pediatrics;Apr1975, Vol. 14 Issue 4, p321 

    The article discusses measles. In 1967, the Federal Government stated that a program involving measles immunization and surveillance could wipe out the disease. Initially, the trend was in the direction of these optimistic hopes. The number of cases in the United States decreased each year to a...

  • Monkey virus may be cleared of cancer link. Pearson, Helen // Nature;9/30/2004, Vol. 431 Issue 7008, p495 

    Reports that laboratory contamination could have lent unwarranted support to the contentious idea that a monkey virus causes certain types of cancer. Study to tackle a long-standing disagreement in cancer biology about whether simian virus 40, which contaminated stocks of polio vaccine in the...

  • SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen. Lowe, D. B.; Shearer, M. H.; Jumper, C. A.; Kennedy, R. C. // Cellular & Molecular Life Sciences;Apr2007, Vol. 64 Issue 7/8, p803 

    SV40 was discovered as a contaminate of poliovirus vaccine lots distributed to millions of individuals in the United States between 1955 and 1963 while contaminated vaccine batches were later circulated worldwide. After SV40 was observed to cause in vitro animal and human cell transformations...

  • Live Measles Vaccine Expressing the Secreted Form of the West Nile Virus Envelope Glycoprotein Protects against West Nile Virus Encephalitis. Desprès, Philippe; Combredet, Chantal; Frenkiel, Marie-Pascale; Lorin, Clarisse; Brahic, Michel; Tangy, Frédéric // Journal of Infectious Diseases;1/15/2005, Vol. 191 Issue 2, p207 

    The Schwarz strain of measles virus (MV), a live attenuated RNA virus, is one of the safest and most effective human vaccines available. Immunization with MV vaccine expressing heterologous antigen is an attractive strategy to prevent emerging viral diseases. West Nile virus (WNV), which...

  • Presence and role of Simian Virus 40 (SV40) in malignant pleural mesothelioma. Hmeljak, Julija; Cör, Andrej // Radiology & Oncology;2009, Vol. 43 Issue 1, p9 

    Background. Evidence of a possible role of viruses in cancer first emerged in the early 1900s and was confirmed after the discovery of Epstein-Barr virus (EBV) in Burkitt's lymphoma cells. Thereafter, several oncogenic viruses and retroviruses were characterised. It is estimated that 15% of...

  • 968. Next Generation Measles Virus Vectors for Oncolytic Therapy: Targeted, Armed and Stealth. Ungerechts, Guy; Springfeld, Christoph; Fielding, Adele; Cattaneo, Roberto // Molecular Therapy;Jun2006, Vol. 13, pS373 

    Infection with wild-type measles virus (MV), a negative-stranded RNA virus of the family Paramyxoviridae, has been associated with spontaneous remissions in patients with lymphoma and leukaemia. In addition, studies with lymphoma, myeloma, glioma and ovarian cancer xenografts have documented...

  • Cell and molecular biology of simian virus 40: Implications for human infections and disease. Butel, Janet S.; Lednicky, John A. // JNCI: Journal of the National Cancer Institute;01/20/99, Vol. 91 Issue 2, p119 

    Presents information on a study which focused on the aspects of replication and cell transformation of Simian virus 40 (SV40). Implications for human infections and disease pathogenesis; History of SV40; Classification of SV40; SV40 and gene products.

  • Short hairpin RNA-mediated inhibition of measles virus replication in vitro. Jun-Yan Shi; Bing Liu; Mei-Lian Wang; En-Jie Luo // Canadian Journal of Microbiology;Jan2010, Vol. 56 Issue 1, p77 

    Rab9 has been identified as a key component for the replication of measles virus (MV). In this study, gene-specific shRNAs were developed to suppress the replication of MV in culture cells by silencing the expression of Rab9 GTPase gene. Rab9 GTPase gene-specific shRNAs were designed and cloned...

  • The Influence of HIV-1 Exposure and Infection on Levels of Passively Acquired Antibodies to Measles Virus in Zambian Infants. Scott, Susana; Moss, William J.; Cousens, Simon; Beeler, Judy A.; Audet, Susette A.; Mugala, Nanthalile; Quinn, Thomas C.; Griffin, Diane E.; Cutts, Felicity T. // Clinical Infectious Diseases;12/1/2007, Vol. 45 Issue 11, p1417 

    Background. The age at which passively acquired antibodies are lost is critical to determining the optimal age for measles vaccination. Little is known about the influence of human immunodeficiency virus type 1 (HIV-1) infection on levels of prevaccination antibodies to measles virus. Methods....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics